Grant: CIHR Fellowship
Direct Payment
$129,167.00
Identification of cellular factors essential for Ebola virus and lassa fever virus entry.
EF 2011-12
Résumé
Ebola virus and lassa fever virus belong to enveloped RNA viruses that cause severe hemorrhagic fever with a lethality rate that can reach up to 90%. The increasing number of outbreaks in endemic regions of Africa and their potential use for biological warfare are alarming. Importantly, there is no available vaccine or effective therapy against these viruses, and this is partly due to the poor understanding of the underlying mechanisms of virus entry into host cells. We propose to investigate Ebola virus and lassa fever virus entry using state-of-the-art technology to screen for cellular factors that play critical roles during infection. The discovery of cellular proteins involved in virus entry will help to better understand how these viruses initiate infection. Our study will ultimately lead to the development of new antiviral drugs that can help in blocking viral entry and spread, which can have a great impact in the fight against these deadly viruses.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
242508
Name
Côté Marceline
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identification of cellular factors essential for Ebola virus and lassa fever virus entry.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$129,167
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cell-Based Assay; Cellular Factors; Click-Chemistry; Ebola Virus; Fusion Mechanism; Lassa Fever Virus; Mass Spectrometry; Photoactivatable Compounds; Small Inhibiting Molecules Screen; Viral Entry
Abstract
Ebola virus and lassa fever virus belong to enveloped RNA viruses that cause severe hemorrhagic fever with a lethality rate that can reach up to 90%. The increasing number of outbreaks in endemic regions of Africa and their potential use for biological warfare are alarming. Importantly, there is no available vaccine or effective therapy against these viruses, and this is partly due to the poor understanding of the underlying mechanisms of virus entry into host cells. We propose to investigate Ebola virus and lassa fever virus entry using state-of-the-art technology to screen for cellular factors that play critical roles during infection. The discovery of cellular proteins involved in virus entry will help to better understand how these viruses initiate infection. Our study will ultimately lead to the development of new antiviral drugs that can help in blocking viral entry and spread, which can have a great impact in the fight against these deadly viruses.
Competitiondate
201110
Approvedterm2
2 yrs 7 mths
Pinamesdelim
Côté, Marceline
Approvedterm
2 ans 7 mois
Cihrcontribution2
~ $129,167~ $0~